• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌患者的全身免疫微环境及调控网络分析

Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma.

作者信息

Liu Libao, Xu Shilei, Huang Lei, He Jinyuan, Liu Gang, Ma Shaohong, Weng Yimin, Huang Shaohong

机构信息

Department of Cardiothoracic Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Department of General Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

Transl Cancer Res. 2021 Jun;10(6):2859-2872. doi: 10.21037/tcr-20-2275.

DOI:10.21037/tcr-20-2275
PMID:35116596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8797838/
Abstract

BACKGROUND

This study applied a complex bioinformatics analysis to explore the hub regulators and immune network to further elucidate the molecular mechanisms of lung adenocarcinoma (LUAD) immune regulation.

METHODS

LUAD immunological microenvironment features and microenvironment-related differential expression genes (DEGs) were identified by ESTIMATE algorithm and linear models for microarray analyses (LIMMA), respectively. CIBERSORT and Igraph algorithms were applied to construct the LUAD-related immunocyte infiltration and regulatory network. Kaplan-Meier survival analysis, and univariate and multivariate Cox analysis were used to predict independent risk factors and screen for the hub genes. In addition, hub genes-correlated gene set enrichment analysis (GSEA), tumor mutation burden (TMB), and clinic pathological relation analyses were also performed.

RESULTS

Stromal, immune, and microenvironment comprehensive features (ESTIMATE score) were associated with overall survival (OS) in LUAD patients (all, P<0.05). T-cell activation, chemokine activity, and immune effect or dysfunction gene ontology maps were associated with the LUAD immune microenvironment. The immune infiltration cell subtypes mast cells (masT-cells) resting [The Cancer Genome Atlas (TCGA): P=0.01; Gene Expression Omnibus (GEO): P=1.79e-05] and activated T-cells (CD4 memory) (TCGA: P<0.01; GEO: P=8.52e-05) were found to have an important role in the immune cell regulatory network. Finally, [univariate hazard ratio (HR) =0.80, 95% confidence interval (CI): 0.69-0.93, P<0.01; multivariate HR =0.59, 95% CI: 0.40-0.86, P=0.01] and (univariate HR =0.78, 95% CI: 0.69-0.89, P<0.01; multivariate HR =0.72, 95% CI: 0.58-0.90, P<0.01) were correlated with the T-cell receptor signaling pathway and anaplastic lymphoma kinase (ALK) fusion (: P=0.034; : P=0.050), and were considered as candidate biomarkers. A significant relation between expression level and TMB (P=3.6e-05) was identified, while no relation was detected for (P=0.11).

CONCLUSIONS

The T-cell activation and activated T-cell (CD4 memory) pathways were predominantly involved in LUAD immune microenvironment regulation. The expression levels of and were significantly correlated with the T-cell receptor signaling pathway and LUAD TMB, and were independent risk factors for OS.

摘要

背景

本研究应用复杂的生物信息学分析来探索核心调节因子和免疫网络,以进一步阐明肺腺癌(LUAD)免疫调节的分子机制。

方法

分别通过ESTIMATE算法和微阵列分析线性模型(LIMMA)鉴定LUAD免疫微环境特征和与微环境相关的差异表达基因(DEG)。应用CIBERSORT和Igraph算法构建与LUAD相关的免疫细胞浸润和调节网络。采用Kaplan-Meier生存分析、单因素和多因素Cox分析来预测独立危险因素并筛选核心基因。此外,还进行了与核心基因相关的基因集富集分析(GSEA)、肿瘤突变负担(TMB)和临床病理关系分析。

结果

基质、免疫和微环境综合特征(ESTIMATE评分)与LUAD患者的总生存期(OS)相关(均P<0.05)。T细胞活化、趋化因子活性以及免疫效应或功能障碍基因本体图谱与LUAD免疫微环境相关。发现免疫浸润细胞亚群静息肥大细胞(masT细胞)[癌症基因组图谱(TCGA):P=0.01;基因表达综合数据库(GEO):P=1.79e-05]和活化T细胞(CD4记忆细胞)(TCGA:P<0.01;GEO:P=8.52e-05)在免疫细胞调节网络中起重要作用。最后发现,[单因素风险比(HR)=0.80,95%置信区间(CI):0.69-0.93,P<0.01;多因素HR =0.59,95%CI:0.40-0.86,P=0.01]和[单因素HR =0.78,95%CI:0.69-0.89,P<0.01;多因素HR =0.72,95%CI:0.58-0.90,P<0.01]与T细胞受体信号通路和间变性淋巴瘤激酶(ALK)融合相关(:P=0.034;:P=0.050),并被视为候选生物标志物。发现表达水平与TMB之间存在显著关系(P=3.6e-05),而未检测到与之间的关系(P=0.11)。

结论

T细胞活化和活化T细胞(CD4记忆细胞)途径主要参与LUAD免疫微环境调节。和的表达水平与T细胞受体信号通路和LUAD TMB显著相关,并且是OS的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/349b6fe9327b/tcr-10-06-2859-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/650890f1b72b/tcr-10-06-2859-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/b74a62bdd0fa/tcr-10-06-2859-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/ec1e4be4e963/tcr-10-06-2859-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/088220c875c4/tcr-10-06-2859-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/349b6fe9327b/tcr-10-06-2859-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/650890f1b72b/tcr-10-06-2859-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/b74a62bdd0fa/tcr-10-06-2859-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/ec1e4be4e963/tcr-10-06-2859-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/088220c875c4/tcr-10-06-2859-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444c/8797838/349b6fe9327b/tcr-10-06-2859-f5.jpg

相似文献

1
Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma.肺腺癌患者的全身免疫微环境及调控网络分析
Transl Cancer Res. 2021 Jun;10(6):2859-2872. doi: 10.21037/tcr-20-2275.
2
Tumor microenvironment related novel signature predict lung adenocarcinoma survival.肿瘤微环境相关的新型标志物可预测肺腺癌的生存期。
PeerJ. 2021 Jan 14;9:e10628. doi: 10.7717/peerj.10628. eCollection 2021.
3
Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.肺腺癌肿瘤微环境中预后基因的分析
PeerJ. 2020 Jul 23;8:e9530. doi: 10.7717/peerj.9530. eCollection 2020.
4
Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma.鉴定一种用于预测肺腺癌预后的新型肿瘤微环境相关八基因特征
Front Mol Biosci. 2020 Sep 23;7:571641. doi: 10.3389/fmolb.2020.571641. eCollection 2020.
5
Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.糖酵解定义了具有不同突变特征和免疫浸润特征的肺腺癌的两个预后亚组。
Front Cell Dev Biol. 2021 Jul 22;9:645482. doi: 10.3389/fcell.2021.645482. eCollection 2021.
6
Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.综合分析以鉴定肺腺癌的一种新型诊断标志物及其免疫浸润图谱。
Front Oncol. 2023 Jun 20;13:1199608. doi: 10.3389/fonc.2023.1199608. eCollection 2023.
7
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.新型基质/免疫评分相关 P2RY12 在肺腺癌微环境中的预后价值及免疫浸润分析。
Int Immunopharmacol. 2021 Sep;98:107734. doi: 10.1016/j.intimp.2021.107734. Epub 2021 Jun 25.
8
Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma.综合分析确定DNA损伤修复相关基因HCLS1与肺腺癌的良好预后相关。
Transl Cancer Res. 2023 Oct 31;12(10):2613-2628. doi: 10.21037/tcr-23-921. Epub 2023 Oct 24.
9
Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors.连环蛋白α-2突变改变接受免疫检查点抑制剂治疗的肺腺癌患者的免疫微环境。
Front Pharmacol. 2021 Jun 7;12:645862. doi: 10.3389/fphar.2021.645862. eCollection 2021.
10
CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma.CD1B是一种与肿瘤突变负荷相关的潜在预后生物标志物,并促进肺腺癌的抗肿瘤免疫。
Int J Gen Med. 2022 Apr 7;15:3809-3826. doi: 10.2147/IJGM.S352851. eCollection 2022.

引用本文的文献

1
Transcription factor-target gene regulatory network analysis in human lung adenocarcinoma.人肺腺癌中的转录因子-靶基因调控网络分析
J Thorac Dis. 2023 Dec 30;15(12):6996-7012. doi: 10.21037/jtd-23-1688. Epub 2023 Dec 26.
2
overexpression inhibits the growth and metastasis of lung adenocarcinoma and is correlated with a dismal prognosis.过表达抑制肺腺癌的生长和转移,并与预后不良相关。
Aging (Albany NY). 2024 Jan 18;16(2):1605-1619. doi: 10.18632/aging.205446.
3
is a novel prognostic biomarker in endometrial cancer and is associated with immune infiltration.

本文引用的文献

1
Chemoresistance in mesenchymal lung cancer cells is correlated to high regulatory T cell presence in the tumor microenvironment.间质型肺癌细胞的化疗耐药性与肿瘤微环境中调节性 T 细胞的高存在相关。
IUBMB Life. 2019 Jul;71(7):986-991. doi: 10.1002/iub.2043. Epub 2019 May 8.
2
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
3
New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx.
是子宫内膜癌中一种新的预后生物标志物,且与免疫浸润相关。
Transl Cancer Res. 2023 Dec 31;12(12):3641-3652. doi: 10.21037/tcr-23-697. Epub 2023 Nov 21.
4
Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors.紫杉叶素通过下调与免疫逃逸因子呈现新颖且强关联的基因来抑制非小细胞肺癌的生长。
Cancers (Basel). 2023 Sep 30;15(19):4818. doi: 10.3390/cancers15194818.
5
Overexpression of TWF1 promotes lung adenocarcinoma progression and is associated with poor prognosis in cancer patients through the MMP1 signaling pathway.TWF1的过表达通过MMP1信号通路促进肺腺癌进展,并与癌症患者的不良预后相关。
J Thorac Dis. 2023 May 30;15(5):2644-2658. doi: 10.21037/jtd-23-395. Epub 2023 May 22.
6
Harmine loaded Au@MSNs@PEG@Asp6 nano-composites for treatment of spinal metastasis from lung adenocarcinoma by targeting ANXA9 experiment.通过靶向膜联蛋白A9实验,负载哈尔明的金@介孔二氧化硅纳米颗粒@聚乙二醇@天冬酰胺纳米复合材料用于治疗肺腺癌脊柱转移。
Transl Lung Cancer Res. 2023 May 31;12(5):1062-1077. doi: 10.21037/tlcr-23-191. Epub 2023 May 26.
7
LRP1B mutation is associated with tumor immune microenvironment and progression-free survival in lung adenocarcinoma treated with immune checkpoint inhibitors.LRP1B突变与接受免疫检查点抑制剂治疗的肺腺癌的肿瘤免疫微环境和无进展生存期相关。
Transl Lung Cancer Res. 2023 Mar 31;12(3):510-529. doi: 10.21037/tlcr-23-39. Epub 2023 Mar 27.
8
Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma.在肺腺癌患者中鉴定并验证一种具有潜在预后和免疫治疗价值的新型吞噬作用调节因子相关特征。
Front Oncol. 2022 Nov 2;12:988332. doi: 10.3389/fonc.2022.988332. eCollection 2022.
9
Genomic Effect of DNA Methylation on Gene Expression in Colorectal Cancer.DNA甲基化对结直肠癌基因表达的基因组效应
Biology (Basel). 2022 Sep 23;11(10):1388. doi: 10.3390/biology11101388.
TCGAbiolinks 包中的新功能,用于研究和整合来自 GDC 和 GTEx 的癌症数据。
PLoS Comput Biol. 2019 Mar 5;15(3):e1006701. doi: 10.1371/journal.pcbi.1006701. eCollection 2019 Mar.
4
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer.靶向 DNA 损伤反应通过 STING 介导的 T 细胞激活促进小细胞肺癌中的抗肿瘤免疫。
Cancer Discov. 2019 May;9(5):646-661. doi: 10.1158/2159-8290.CD-18-1020. Epub 2019 Feb 18.
5
Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.人肿瘤相关单核细胞/巨噬细胞及其对早期肺癌 T 细胞反应的调控。
Sci Transl Med. 2019 Feb 13;11(479). doi: 10.1126/scitranslmed.aat1500.
6
Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer.晚期肺癌患者外周血 T 细胞受体谱特征及预后意义。
Int J Cancer. 2019 Sep 1;145(5):1423-1431. doi: 10.1002/ijc.32145. Epub 2019 Jan 31.
7
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
8
KEYNOTE-025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1-positive advanced non-small-cell lung cancer.KEYNOTE-025:帕博利珠单抗治疗既往接受治疗的 PD-L1 阳性晚期非小细胞肺癌日本患者的 1b 期研究。
Cancer Sci. 2019 Mar;110(3):1012-1020. doi: 10.1111/cas.13932. Epub 2019 Feb 16.
9
Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival.去势抵抗性前列腺癌六基因预后模型的基因变异与生存的关联
Prostate. 2019 Jan;79(1):73-80. doi: 10.1002/pros.23712. Epub 2018 Aug 23.
10
Transcriptomic Predictors of Paradoxical Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.矛盾性隐球菌病相关免疫重建炎症综合征的转录组学预测指标
Open Forum Infect Dis. 2018 Jul 2;5(7):ofy157. doi: 10.1093/ofid/ofy157. eCollection 2018 Jul.